Sign In
Buy ACSAY
$18.00
-0.0700 (-0.387%)
At Close: Nov 17, 2025
ACS ACTIVIDADS CNS ADR Earnings Calls
Jun 30, 2025
| Release date | Jul 29, 2025 |
| EPS estimate | - |
| EPS actual | $0.240 |
| Revenue estimate | 28.47B |
| Revenue actual | 14.504B |
| Revenue Surprise | -49.05% |
Mar 31, 2025
| Release date | May 13, 2025 |
| EPS estimate | - |
| EPS actual | $0.164 |
| Revenue estimate | 12.483B |
| Revenue actual | 12.925B |
| Revenue Surprise | 3.54% |
Dec 31, 2024
| Release date | Feb 27, 2025 |
| EPS estimate | - |
| EPS actual | $0.330 |
| Revenue estimate | 11.021B |
| Revenue actual | 12.357B |
| Revenue Surprise | 12.12% |
Sep 30, 2024
| Release date | Nov 12, 2024 |
| EPS estimate | - |
| EPS actual | $0.81 |
| Revenue estimate | - |
| Revenue actual | 12.012B |
Last 4 Quarters for ACS ACTIVIDADS CNS ADR
Below you can see how ACSAY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Sep 30, 2024
| Release date | Nov 12, 2024 |
| Price on release | $8.78 |
| EPS estimate | - |
| EPS actual | $0.81 |
| Date | Price |
|---|---|
| Nov 06, 2024 | $9.36 |
| Nov 07, 2024 | $9.33 |
| Nov 08, 2024 | $9.08 |
| Nov 11, 2024 | $8.88 |
| Nov 12, 2024 | $8.78 |
| Nov 13, 2024 | $8.58 |
| Nov 14, 2024 | $8.54 |
| Nov 15, 2024 | $8.60 |
| Nov 18, 2024 | $8.62 |
| 4 days before | -6.20% |
| 4 days after | -1.82% |
| On release day | -2.37% |
| Change in period | -7.91% |
Dec 31, 2024
| Release date | Feb 27, 2025 |
| Price on release | $10.74 |
| EPS estimate | - |
| EPS actual | $0.330 |
| Date | Price |
|---|---|
| Feb 21, 2025 | $10.70 |
| Feb 24, 2025 | $10.47 |
| Feb 25, 2025 | $10.67 |
| Feb 26, 2025 | $10.80 |
| Feb 27, 2025 | $10.74 |
| Feb 28, 2025 | $10.59 |
| Mar 03, 2025 | $10.91 |
| Mar 04, 2025 | $11.05 |
| Mar 05, 2025 | $11.89 |
| 4 days before | 0.374% |
| 4 days after | 10.71% |
| On release day | -0.465% |
| Change in period | 11.12% |
Mar 31, 2025
| Release date | May 13, 2025 |
| Price on release | $12.78 |
| EPS estimate | - |
| EPS actual | $0.164 |
| Date | Price |
|---|---|
| May 07, 2025 | $12.54 |
| May 08, 2025 | $12.61 |
| May 09, 2025 | $12.65 |
| May 12, 2025 | $12.41 |
| May 13, 2025 | $12.78 |
| May 14, 2025 | $12.78 |
| May 15, 2025 | $13.01 |
| May 16, 2025 | $13.15 |
| May 19, 2025 | $13.42 |
| 4 days before | 1.91% |
| 4 days after | 5.01% |
| On release day | 0% |
| Change in period | 7.02% |
Jun 30, 2025
| Release date | Jul 29, 2025 |
| Price on release | $14.32 |
| EPS estimate | - |
| EPS actual | $0.240 |
| Date | Price |
|---|---|
| Jul 23, 2025 | $14.17 |
| Jul 24, 2025 | $14.38 |
| Jul 25, 2025 | $14.20 |
| Jul 28, 2025 | $14.07 |
| Jul 29, 2025 | $14.32 |
| Jul 30, 2025 | $14.04 |
| Jul 31, 2025 | $13.75 |
| Aug 01, 2025 | $13.55 |
| Aug 04, 2025 | $13.71 |
| 4 days before | 1.07% |
| 4 days after | -4.29% |
| On release day | -1.96% |
| Change in period | -3.26% |
ACS ACTIVIDADS CNS ADR Earnings Call Transcript Summary of Q2 2025
In the first half of 2025, ACS Group reported robust financial results with sales increasing by 28.6% to EUR 24.1 billion and a notable growth in ordinary net profit of 17% to EUR 392 million. The company's strong cash flow generation continued, with a net operating cash flow of EUR 1.8 billion over the last 12 months. The order backlog grew by 12% to EUR 89.3 billion, supported by a healthy book-to-bill ratio of 1.2x. CEO Juan Santamaria emphasized the group's ongoing strategic investments in data centers, biopharma, and defense, and confirmed confidence in sustained net profit growth for the rest of the year. ACS's focus on capital allocation, operational efficiency, and long-term value creation were highlighted as important for future growth.
ACS ACTIVIDADS CNS ADR Earnings History
Earnings Calendar
FAQ
What is the ACSAY price-to-earnings (P/E) ratio?
ACSAY P/E ratio as of Nov 17, 2025 (TTM) is 23.01.
What are ACS ACTIVIDADS CNS ADR's retained earnings?
On its balance sheet, ACS ACTIVIDADS CNS ADR reported retained earnings of $14.50 billion for the latest quarter ending Jun 30, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
